USCF Sustainable [ZSB] vs Sagimet Biosciences [SGMT] Detailed Stock Comparison
USCF Sustainable
NYSE
Loading...
Sagimet Biosciences
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 18 vital metrics comparison: USCF Sustainable wins in 5 metrics, Sagimet Biosciences wins in 7 metrics, with 0 ties. Sagimet Biosciences appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | USCF Sustainable | Sagimet Biosciences | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 26.11 | -5.04 | Sagimet Biosciences |
| Price-to-Book Ratio | 4.89 | 1.82 | Sagimet Biosciences |
| Debt-to-Equity Ratio | 2.06 | 0.12 | Sagimet Biosciences |
| PEG Ratio | 0.00 | -0.18 | Sagimet Biosciences |
| EV/EBITDA | 26.84 | -2.08 | Sagimet Biosciences |
| Profit Margin (TTM) | -1.78% | 0.00% | Sagimet Biosciences |
| Operating Margin (TTM) | N/A | 0.00% | N/A |
| Return on Equity | 0.90% | -37.89% | USCF Sustainable |
| Return on Assets (TTM) | 0.30% | -25.61% | USCF Sustainable |
| Free Cash Flow (TTM) | N/A | $-42.44M | N/A |
| 1-Year Return | 17.00% | 100.00% | Sagimet Biosciences |
| Price-to-Sales Ratio (TTM) | 0.00 | N/A | N/A |
| Enterprise Value | $880.30M | $113.45M | USCF Sustainable |
| EV/Revenue Ratio | 6.55 | N/A | N/A |
| Gross Profit Margin (TTM) | -102.87% | N/A | N/A |
| Revenue per Share (TTM) | $1 | $0 | USCF Sustainable |
| Earnings per Share (Diluted) | $0.04 | $-1.86 | USCF Sustainable |
| Beta (Stock Volatility) | N/A | 3.27 | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
USCF Sustainable vs Sagimet Biosciences Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| USCF Sustainable | 0.29% | 4.07% | 12.85% | 17.98% | 17.49% | 30.29% |
| Sagimet Biosciences | -10.96% | 20.39% | 25.11% | -9.26% | 279.74% | 91.98% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| USCF Sustainable | 17.00% | 5,921.43% | 5,921.43% | 5,921.43% | 5,921.43% | 5,921.43% |
| Sagimet Biosciences | 100.00% | -45.92% | -45.92% | -45.92% | -45.92% | -45.92% |
Performance & Financial Health Analysis: USCF Sustainable vs Sagimet Biosciences
| Metric | ZSB | SGMT |
|---|---|---|
| Market Information | ||
| Market Cap | $0 | $237.73M |
| Market Cap Category | Micro cap | Micro cap |
| 10 Day Avg. Volume | 530 | 389,180 |
| 90 Day Avg. Volume | 533 | 466,160 |
| Last Close | $13.66 | $7.68 |
| 52 Week Range | $12.03 - $15.51 | $1.73 - $11.41 |
| % from 52W High | -11.93% | -32.73% |
| All-Time High | $26.63 (Jan 30, 2023) | $20.71 (Jan 22, 2024) |
| % from All-Time High | -48.70% | -62.92% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.19% | N/A |
| Quarterly Earnings Growth | -0.58% | N/A |
| Financial Health | ||
| Profit Margin (TTM) | -0.02% | 0.00% |
| Operating Margin (TTM) | N/A | 0.00% |
| Return on Equity (TTM) | 0.01% | -0.38% |
| Debt to Equity (MRQ) | 2.06 | 0.12 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $3.22 | $4.04 |
| Cash per Share (MRQ) | N/A | $3.86 |
| Operating Cash Flow (TTM) | $46.00M | $-54,230,000 |
| Levered Free Cash Flow (TTM) | $4.30M | $-35,545,376 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | $0.00 | N/A |
Valuation & Enterprise Metrics Analysis: USCF Sustainable vs Sagimet Biosciences
| Metric | ZSB | SGMT |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 26.11 | -5.04 |
| Forward P/E | N/A | -2.07 |
| PEG Ratio | 0.00 | -0.18 |
| Price to Sales (TTM) | 0.00 | N/A |
| Price to Book (MRQ) | 4.89 | 1.82 |
| Market Capitalization | ||
| Market Capitalization | $0 | $237.73M |
| Enterprise Value | $880.30M | $113.45M |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 6.55 | N/A |
| Enterprise to EBITDA | 26.84 | -2.08 |
| Risk & Other Metrics | ||
| Beta | N/A | 3.27 |
| Book Value per Share (MRQ) | $3.22 | $4.04 |
Financial Statements Comparison: USCF Sustainable vs Sagimet Biosciences
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ZSB | SGMT |
|---|---|---|
| Revenue/Sales | N/A | $0 |
| Cost of Goods Sold | N/A | N/A |
| Gross Profit | N/A | N/A |
| Research & Development | N/A | $15.34M |
| Operating Income (EBIT) | N/A | $-19.87M |
| EBITDA | N/A | $-19.87M |
| Pre-Tax Income | N/A | $-18.18M |
| Income Tax | N/A | N/A |
| Net Income (Profit) | N/A | $-18.18M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ZSB | SGMT |
|---|---|---|
| Cash & Equivalents | N/A | $64.72M |
| Total Current Assets | N/A | $146.07M |
| Total Current Liabilities | N/A | $7.18M |
| Long-Term Debt | N/A | N/A |
| Total Shareholders Equity | N/A | $138.99M |
| Retained Earnings | N/A | $-313.49M |
| Property, Plant & Equipment | N/A | $38,000 |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ZSB | SGMT |
|---|---|---|
| Operating Cash Flow | N/A | $-16.70M |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | $-14.54M |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | ZSB | SGMT |
|---|---|---|
| Shares Short | N/A | 3.11M |
| Short Ratio | N/A | 5.61 |
| Short % of Float | N/A | 0.11% |
| Average Daily Volume (10 Day) | 530 | 389,180 |
| Average Daily Volume (90 Day) | 533 | 466,160 |
| Shares Outstanding | 117.78M | 32.20M |
| Float Shares | N/A | 22.63M |
| % Held by Insiders | N/A | 0.10% |
| % Held by Institutions | N/A | 0.29% |
Dividend Analysis & Yield Comparison: USCF Sustainable vs Sagimet Biosciences
| Metric | ZSB | SGMT |
|---|---|---|
| Last 12-Month Dividend | $0.00 | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | $0.20 | N/A |
| 3-Year Avg Dividend Yield | 3.59% | N/A |
| 3-Year Total Dividends | $0.60 | N/A |
| Ex-Dividend Date | Dec 27, 2023 | N/A |